Sachdeva, M., Dhingra, S., & Parle, M. (2017). Dapagliflozin: a new adjunct in the treatment of Type 2 diabetes mellitus. International Journal of Basic & Clinical Pharmacology, 3(4), 741–747. Retrieved from https://www.ijbcp.com/index.php/ijbcp/article/view/1067